PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 25, 2023American Heart JournalOpen Access

Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics

View Full Paper
Ask AI
Bookmark
Share

Authors

SNStephen J. NichollsDBDeepak L. BhattJBJohn B. Buse

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nicholls et al. (2023) studied this question.

synapsesocial.com/papers/69a607599cf1ac82ad736679https://doi.org/10.1016/j.ahj.2023.09.007
View Full Paper
Ask AI
Bookmark
Share